Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.72 - $58.88 $3.23 Million - $5.17 Million
-87,860 Reduced 55.83%
69,520 $3.14 Million
Q2 2024

Aug 13, 2024

BUY
$27.95 - $53.0 $300,462 - $569,750
10,750 Added 7.33%
157,380 $7.76 Million
Q1 2024

May 15, 2024

BUY
$32.28 - $41.5 $499,371 - $642,005
15,470 Added 11.79%
146,630 $5.03 Million
Q4 2023

Feb 14, 2024

BUY
$15.08 - $38.61 $1.98 Million - $5.06 Million
131,160 New
131,160 $4.83 Million
Q4 2019

Feb 14, 2020

SELL
$21.0 - $26.48 $2.99 Million - $3.77 Million
-142,416 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$23.72 - $33.99 $348,019 - $498,701
14,672 Added 11.49%
142,416 $3.4 Million
Q2 2019

Aug 13, 2019

BUY
$21.74 - $33.2 $2.78 Million - $4.24 Million
127,744 New
127,744 $3.71 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $1.51B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.